Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 27 - Drugs for disorders of the senses
Patents for A61P 27 - Drugs for disorders of the senses (53,017)
10/2005
10/19/2005EP1586322A2 Compositions for inhibition of anglogenesis
10/19/2005EP1586316A1 Aqueous liquid preparation containing 2-amino-3-(4-bromobenzoyl)phenylacetic acid
10/19/2005EP1585743A1 2-(1h-indazol-6-ylamino)- benzamide compounds as protein kinases inhibitors useful for the treatment of ophthalmic diseases
10/19/2005EP1585545A2 Methods of inducing and maintaining immune tolerance
10/19/2005EP1585523A2 Use of purine derivatives for inducing differentiation of supernumerary hair cells and deiters' cells in the developing organ of corti for treating deafness
10/19/2005EP1585522A2 Quinazolinones as potassium channel modulators
10/19/2005EP1463714A4 Vanilloid receptor ligands and their use in treatments
10/19/2005EP1397170B1 Safety shield system for prefilled syringes
10/19/2005EP1345616A4 Reducing cellular damage in the human body
10/19/2005EP1339438B1 Preventing transplant rejection in the eye
10/19/2005EP1311263B1 Fused pyrrolocarbazoles against inflammation
10/19/2005EP1109570B1 Modulation of memory effector t-cells with a cd2 binding agent
10/19/2005EP1016406B1 Ophthalmic compositions for soft contact lens comprising terpenoid
10/19/2005CN1685055A Bone morphogenic proteins (BMP), BMP receptors and BMP binding proteins and their use in the diagnosis and treatment of glaucoma
10/19/2005CN1684959A 2-(3-aminoaryl)amino-4-aryl-thiazoles and their use as C-KIT inhibitors
10/19/2005CN1684957A Substituted thienyl-hydroxamic acids as histone deacetylase inhibitors
10/19/2005CN1684952A Novel piperidine derivatives for use in the treatment of chemokine mediated disease states
10/19/2005CN1684738A Use of cytokine synthesis inhibitors for the treatment of dry eye disorders
10/19/2005CN1684702A Method of treating tumors
10/19/2005CN1684695A Vitreoretinal tamponades based on fluorosilicone fluids
10/19/2005CN1684689A Glaucoma-treating agent consisting of RHo kinase inhibitor and prostaglandin
10/19/2005CN1684688A Stable eye lotion containing latanoprost as active ingredient
10/19/2005CN1684673A Electrospun amorphous pharmaceutical compositions
10/19/2005CN1683365A Substituted dioxopentacyclic derivative and its use in preparing neuro regulator
10/19/2005CN1683340A 2-nitro-gen-dicyclic [2, 2, 1] hepta-5-ene-3-carboxylic derivative and its use preparing neuro regulator
10/19/2005CN1682968A Chinese medicine composition and its soft capsule
10/19/2005CN1682967A Fleabane oral disintegration tablet and its preparing process
10/19/2005CN1682799A External use Chinese medicine preparation for treating bacterial and viral conjunctivitis and keratitis and its preparing process
10/19/2005CN1682742A Use of 23-hydroxy betulic acid in inhibiting blood vessel formation
10/19/2005CN1682717A Medicinal preparation and its preparing method
10/19/2005CN1682713A Use of ampelopsin in preparing medicine for treating diseases related with aldose reductase
10/19/2005CN1682710A Water soluble soybean aglycone medicinal composition and its preparing method
10/19/2005CN1682682A Hair tension and hardness improving agent
10/19/2005CN1223608C Caspase-8 interacting proteins
10/19/2005CN1223346C Pharmaceutical and nutritional compositions containing essential fatty acids and homocysteine-lowering agents
10/18/2005US6956050 Imidazole compounds as anti-inflammatory and analgesic agents
10/18/2005US6956033 3,4-dihydroisoquinoline derivative compound and a pharmaceutical agent comprising it as active ingredient
10/18/2005US6955810 Method for the treatment of inflammatory disorders
10/18/2005CA2340138C 2-oxo-imidazolidine-4-carboxylic acid hydroxamide compounds that inhibit matrix metalloproteinases
10/18/2005CA2125730C Novel sulfonylamino pyrimidines
10/13/2005WO2005095587A1 Process for producing somatic stem cell differentiated from embryonic stem cell and use of the same
10/13/2005WO2005094811A1 Pharmaceutical product containing tranilast
10/13/2005US20050228337 Transcutaneous infusion of carbon dioxide for local relief of pain and other ailments
10/13/2005US20050228054 Methods for treating eye disorders
10/13/2005US20050228048 Stable eye drops containing latanoprost as the active ingredient
10/13/2005US20050228018 Chemical compounds
10/13/2005US20050228001 Methods and compositions for treating platelet-related disorders
10/13/2005US20050227997 Selective inhibition of aggrecanase in osteoarthritis treatment
10/13/2005US20050227991 Containing a piperazine ring, e.g., N'-(4-{4-[5-(1,2-dithiolan-3-yl)pentanoyl]-1-piperazinyl)phenyl)-2-thiophenecarboximidamide and intermediates for preparing them; useful for inhibiting NO synthase and regenerating antioxidants
10/13/2005US20050227988 compounds capable of inhibiting, modulating and/or regulating signal transduction of both receptor-type and non-receptor type tyrosine kinases; gliomas, meningomas, cancers, Hodgkin's disease, retinal vascularization; core structure that comprises a benzazocine moiety
10/13/2005US20050227986 Vanilloid receptor ligands and their use in treatments
10/13/2005US20050227979 E.g., 1-[4-(1-Isopropyl-piperidin-4-yloxy)-benzyl]-piperidine and 1-[4-(1-Isopropyl-piperidin-4-yloxy)-benzyl]-azepane; these compounds modulate the activity of the histamine receptor, specifically the H3 receptor, without the inherent problems associated with the presence of an imidazolyl moiety
10/13/2005US20050227969 A piperidin-2-one, 1,3-oxazinan-2-one, or 1,3-thiazinan-2-one compound for treatment of glaucoma, mediating the bone modeling and remodeling processes of the osteoblasts and osteoclasts; 7-{(4S)-4-[(3R)-3-hydroxy-4-phenylbutyl]-2-oxo-1,3-oxazinan-3-yl}heptanoic acid; side effect reduction
10/13/2005US20050227967 Treatment of T-helper cell type 2-mediated immune diseases by retinoid antagonists
10/13/2005US20050227963 Antiinflammatory agents
10/13/2005US20050226877 administration of a function blocking antibody which is capable of binding an epitope of VLA-1; arthritis
10/13/2005CA2560824A1 Use of loteprednol etabonate for the treatment of dry eye
10/12/2005EP1583744A2 Substituted benzylamine derivatives and methods of use
10/12/2005EP1583553A2 Therapeutic use of modulators of notch
10/12/2005EP1583551A1 Composition for preventing the formation of new scar comprising bmp-7
10/12/2005EP1583530A1 2-aminothiazole allosteric enhancers of a1-adenosine receptors
10/12/2005EP1583527A1 Use of hydroxyeicosatetraenoic acid compounds to treat ophthalmic inflammatory disorders
10/12/2005EP1583506A2 Eye-drop vaccine containing copolymer 1 for therapeutic immunization
10/12/2005EP1511765A4 Par-2-activating peptide derivative and pharmaceutical composition using the same
10/12/2005EP1242096B1 Pharmaceutucal compositions for the treatment of dna viral infections comprising a loop diuretic and lithium
10/12/2005EP1224173B1 Pyrazole derivatives as cannabinoid receptor antagonists
10/12/2005CN1681818A Azaindole kinase inhibitors
10/12/2005CN1681815A Compositions useful as inhibitors of GSK-3
10/12/2005CN1681795A Pyrimidyl sulphone amide derivatives as chemokine receptor modulators
10/12/2005CN1681770A Amino-propanol derivatives
10/12/2005CN1681763A Chemical compounds
10/12/2005CN1681557A Methods for treating carbonic anhydrase mediated disorders
10/12/2005CN1681514A A method of treating diabetes mellitus including conditions associated with diabetes mellitus and complications of diabetes mellitus
10/12/2005CN1681508A Novel inhibitors of kinases
10/12/2005CN1680379A 2-pyridinyl-6, 7, 8, 9-tetrahydropyrimido{1, 2-a}pyrimidin-4-one and 7-pyridinyl-1, 3-dihydoimidazo{1, 2-a}pyrimidin-5(1h)one derivatives
10/12/2005CN1680378A Pyrazolo(4, 3-d)pyrimidine derivatives
10/12/2005CN1680371A Tropan derivatives useful in therapy, method for obtaining thereof and intermediate compounds
10/12/2005CN1680358A Composition concerned with isoflavone and the similar and therapeutical method
10/12/2005CN1680341A Valsartan salts
10/12/2005CN1680324A Dihydropyridine soft drugs, and related compositions and methods
10/12/2005CN1680314A 2-oxo-1-pyrrolidine derivatives, process for preparing them and their uses
10/12/2005CN1680259A Aspirin-triggered lipid mediators
10/12/2005CN1679935A Method for treating fibrosis by utilizing integrin alpha 4 subunit antagonist
10/12/2005CN1679914A Medicinal composition of induced glutathione and ebeselen
10/12/2005CN1679791A Ophthalmologic Chinese medicine compound preparation, extracting and making methods and use thereof
10/12/2005CN1679773A Eye-washing and vision-improving liquid
10/12/2005CN1679741A Drug-resistant rapid-acting eyedrops without stimulation
10/12/2005CN1679648A Mailuoning injection and its preparation and quality control
10/12/2005CN1679642A Oral liquid medicine from ferments of armilarilla tabescens
10/12/2005CN1679609A Compound energy mistura fat-soluble vitamins adult preparation and use thereof
10/12/2005CN1679564A Method of treating of demyelinating diseases or conditions
10/12/2005CN1679556A Valdecoxib compositions
10/12/2005CN1679532A Therapeutic and dietary compositions
10/12/2005CN1222523C 3-thiazol-4-yl-pyprolidine derivatives as AMP-specific phosphodiesterase inhibitors
10/12/2005CN1222519C Reverse hydroxamate inhibitors of matrix metalloproteinases
10/12/2005CN1222509C Prostaglandin derives.
10/12/2005CN1222304C Medicine for treating turbid vitrious body and its prepn
10/12/2005CN1222288C Use of 3-substituted oxindole derivatives as KCNQ potassium channel modulators
10/11/2005US6953854 Process for preparing crystalline Form I of cabergoline
10/11/2005US6953853 Phospholipase inhbitors; antiinflammatory agents; respiratory system disorders
1 ... 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 ... 531